Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 1 | BMC Cancer

Fig. 1

From: Osteopontin splice variants are differential predictors of breast cancer treatment responses

Fig. 1

Kaplan-Meier survival curves for patients undergoing hormone therapy. Survival of patients under hormone treatment, distinguished according to low (levels 0–1) versus high (levels 2–3) osteopontin-c staining (top left), low versus high osteopontin-exon 4 staining (top right), or low (1) versus high (2–3) tumor grade (bottom left). The overall survival of patients receiving hormone treatment versus not receiving hormone treatment is shown for comparison on the bottom right. Untreated subgroups are displayed in black, treated subgroups in gray, low marker levels are shown as circles, high marker levels as triangles. The x-axis indicates years since diagnosis, the y-axis reflects % surviving patients

Back to article page